(Teva) resolving all patent litigation related to Axsome’s AUVELITY® (dextromethorphan HBr – bupropion HCl) product. The litigation resulted from submission by Teva of an Abbreviated New Drug ...
(Teva) resolving all patent litigation related to Axsome’s AUVELITY® (dextromethorphan HBr – bupropion HCl) product. The litigation resulted from submission by Teva of an Abbreviated New Drug ...
(Teva) resolving all patent litigation related to Axsome's AUVELITY® (dextromethorphan HBr - bupropion HCl) product. The litigation resulted from submission by Teva of an Abbreviated New Drug ...
The settlement resolves all patent litigation related to Axsome’s Auvelity (dextromethorphan HBr – bupropion HCl ... Teva submitting an Abbreviated New Drug Application to the U.S. Food ...
阿伐曲泊帕片（Avatrombopag Maleate Tablets）适用于择期行诊断性操作或者手术的慢性肝病相关血小板减少症的成年患者。慢性肝病患者不得通过服用本品来恢复正常的血小板计数。 本品主要成分为马来酸阿伐曲泊帕。 【用法用量】 本品为口服给药，应与食物同服 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈